US Patent Issued to Societe des Produits Nestle on Aug. 18 for "Methods and compositions using Bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances" (Swiss Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,651, issued on Aug. 18, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Methods and compositions using Bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances" was invented by Gabriela Bergonzelli Degonda (Bussigny, Switzerland), Tiago Alves Nunes (Bern, Switzerland), Valerie Marquardt (Epalinges, Switzerland) and Jeroen Antonius Johannes Schmitt (Moudon, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to stabilize or improve mood, modulate excessive emotional distress, reduce anxiety, and/...